In recent years, pharmaceutical development utilizing various new drug modalities has made significant impacts on the treatment of diseases such as cancer and genetic disorders, which were previously difficult to manage. As a pharmaceutical distribution company, our new mission is to establish optimized, tailor-made distribution systems to meet the unique needs of specialty pharmaceuticals.
As a subsidiary of Toho Holdings Co., Ltd., Orphan Trust Japan Co., Ltd. maximizes the high-quality distribution functions developed by the group. Our mission is to contribute to the development of businesses specializing in specialty pharmaceuticals and to comprehensively support pharmaceutical companies in drug discovery and development.
Going forward, we will enhance our ability to support the market entry of foreign pharmaceutical companies into Japan and the launch of drug lag and orphan products not yet developed domestically.
To meet the expectations and trust of patients, their families, healthcare professionals, and pharmaceutical companies, we will continue working as a member of the group to establish a safe, reliable, and stable distribution system for specialty pharmaceuticals.
